Watchlist Price Alert

Cartesian Therapeutics In... (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

10.37

0.13 (1.27%)

At close: Jun 13, 2025, 3:59 PM

10.42

0.48%

After-hours: Jun 13, 2025, 04:04 PM EDT

Cartesian Therapeutics Revenue

Cartesian Therapeutics reported an annual revenue of $38.91M, reflecting a 49.64% growth. For the quarter ending March 31, 2025, Cartesian Therapeutics generated $1.1M in revenue.

Revenue (ttm)

$38.91M

Revenue Growth

49.64%

Price / Sales Ratio

7.95

Revenue / Employee

$589.59K

Employees

Market Cap

269.15M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	% Change

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.